Company Announcements

Publication of Amended and Restated Final Terms

Source: RNS
RNS Number : 1643M
Bank of Nova Scotia
09 January 2023
 

 

 

Regulatory Announcement

 

 


The Bank of Nova Scotia

January 9, 2023

 

 

Not for release, publication or distribution, directly or indirectly, in or into the United States.

 

Notice to Noteholders and Publication of Amended and Restated Final Terms

 

The Bank of Nova Scotia has today given notice to Noteholders relating to the 300,000,000 Fixed Rate Senior Notes due 25 January 2034 (Series EMTN370 ISIN XS2436798347) issued on 25 January 2022 (the "Notes") under the U.S.$20,000,000,000 Euro Medium Term Note Programme (the "Programme").  

 

Noteholders have been informed that pursuant to Section 26(i) of the Amended and Restated Agency Agreement dated 20 June 2021 the Final Terms have been amended and restated on 9 January 2023 (the "Amended and Restated Final Terms") as follows to cure ambiguities in the Notes. Item 6 (ii) (Calculation Amount: has been amended to read "100,000" instead of "1,000"), Item 14 (v) (Fixed Coupon Amount[(s)]: has been amended to read "€1,139.00 per Calculation Amount" instead of "€11.39 per Calculation Amount"), Item 20 (Final Redemption Amount of each Senior Note: has been amended to read "100,000 per Calculation Amount" instead of "1,000 per Calculation Amount") and Item 21 (Early Redemption Amount: has been amended to read "100,000 per Calculation Amount" instead of "1,000 per Calculation Amount")

All other Conditions remain unchanged.

The Issuer has today published the Amended and Restated Final Terms and submitted them to the London Stock Exchange. They are available to view at http://www.rns-pdf.londonstockexchange.com/rns/1643M_1-2023-1-9.pdf

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Prospectus and the Amended and Restated Final Terms, may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Amended and Restated Final Terms is not addressed.  Prior to relying on the information contained in the Amended and Restated Final Terms you must ascertain from the Prospectus, as supplemented by these Amended and Restated Final Terms, whether or not you are part of the intended addressees of the information contained therein.

 

The Notes have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act").  Subject to certain exceptions, the Notes may not be offered, sold or delivered in or into the United States or to or for the account or benefit of US persons (as defined in Regulation S under the Securities Act).  No public offering of the Notes is being made in the United States.

 

Your right to access this service is conditional upon complying with the above requirement.

 

UK MiFIR professionals / ECPs-only / No PRIIPs KID - Manufacturer target market (UK MiFIR professionals) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs key information document (KID) has been prepared as not available to retail in EEA.

 

 

 

For further information, please contact

 

The Bank of Nova Scotia

Scotia Plaza

40 Temperance Street, 9th Floor

Toronto, Ontario

Canada M5H 0B4

 

Attn: Managing Director, Term Funding & Capital Management

Tel.: 001 416 860 1784

Fax: 001 416 945 4001

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTDDGDBGXGDGXC